Trial record 1 of 2 for:    tvp1012/501
Previous Study | Return to List | Next Study

Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial

This study is not yet open for participant recruitment.
Verified June 2012 by Rabin Medical Center
Sponsor:
Information provided by (Responsible Party):
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT01709461
First received: October 14, 2012
Last updated: October 16, 2012
Last verified: June 2012
  Purpose

the purpose of the study is to extend the use of Rasagelin Mesylate 1mg per day by subjects who participated in the Adagio TVP 1012/501 according to form 4a for additional three years.


Condition
Parkinson Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Continue Providing Care for Patient Who Participated in the Adagio TVP 1012/501 Clinical Trial

Resource links provided by NLM:


Further study details as provided by Rabin Medical Center:

Estimated Enrollment: 12
Study Start Date: October 2012
  Eligibility

Ages Eligible for Study:   30 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

subjects who took part in the TVP 1012/501 clinical trial and willing to contiue receiving Rasgiline Mesylate.

Criteria

Inclusion Criteria:

  • subjects who are willing to contiue this treatment.
  • subjects who took part in the TVP 1012/501 clinical trail.

Exclusion Criteria:

  • subjects who didn't take part in the TVP 1012/501 clinical trail.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01709461

Contacts
Contact: Ruth Djaldetti, Professor 972-9378218/9 ruthdjal@clalit.org.il
Contact: Yaniv roditi, Msc 972-39236843 yar@clalit.org.il

Locations
Israel
Rabin Medical Center Beilinson Campus Not yet recruiting
Petach Tiqva, Hamerkaz, Israel, 49100
Principal Investigator: Ruth Djaldetti, Professor         
Sponsors and Collaborators
Rabin Medical Center
  More Information

No publications provided

Responsible Party: Rabin Medical Center
ClinicalTrials.gov Identifier: NCT01709461     History of Changes
Other Study ID Numbers: RD 06 - 12
Study First Received: October 14, 2012
Last Updated: October 16, 2012
Health Authority: Israeli: Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on April 17, 2014